How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Factorial Energy, Inc. engages in the development and commercialization of solid-state battery technologies. Its platforms include FEST and Solstice, designed to deliver high-performance, scalable ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
Calculating student loan interest can be pretty straightforward, but how you calculate it will vary depending on whether ...
Factorial Energy Inc. (FAC) - 10-Q - Quarterly Report SEC FilingsFri, Nov 14, 2025 Factorial Energy Inc. (FAC) - 10-Q - Quarterly Report SEC FilingsThu, Aug 14, 2025 ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results